Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,650 | -63,495 | -47,971 | -33,095 | -16,355 |
| Depreciation Amortization | 678 | 3,351 | 2,472 | 1,646 | 798 |
| Accounts payable and accrued liabilities | 2,043 | -144 | -663 | -651 | -810 |
| Other Working Capital | -884 | 81,949 | 447 | 2,797 | 967 |
| Other Operating Activity | 93 | 5,561 | 4,564 | 3,558 | 2,222 |
| Operating Cash Flow | $-15,720 | $27,222 | $-41,151 | $-25,745 | $-13,178 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 13,135 | 13,135 | 13,135 | 12,135 |
| PPE Investments | -395 | -2,350 | -1,484 | -824 | -493 |
| Investing Cash Flow | $-395 | $10,785 | $11,651 | $12,311 | $11,642 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -636 | -2,617 | -1,946 | -1,290 | -594 |
| Common Stock Issued | N/A | 44,796 | 44,699 | 44,699 | 44,699 |
| Common Stock Repurchased | N/A | -290 | -290 | -290 | -290 |
| Other Financing Activity | 380 | 1,994 | 1,689 | 1,154 | 910 |
| Financing Cash Flow | $-256 | $43,883 | $44,152 | $44,273 | $44,725 |
| Beginning Cash Position | 115,577 | 33,687 | 33,687 | 33,687 | 33,687 |
| End Cash Position | 99,206 | 115,577 | 48,339 | 64,526 | 76,876 |
| Net Cash Flow | $-16,371 | $81,890 | $14,652 | $30,839 | $43,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,720 | 27,222 | -41,151 | -25,745 | -13,178 |
| Capital Expenditure | -395 | -2,350 | -1,484 | -824 | -493 |
| Free Cash Flow | -16,115 | 24,872 | -42,635 | -26,569 | -13,671 |